Identification of Behavioural Patterns and CGM Derived Metrics for Optimising Glycaemic Control in People with T2D on Oral Semaglutide: A Trial Protocol

Nynne Sophie Holdt-Caspersen; Claus Dethlefsen; Stine Hangaard; Henrik Bengtsson; Peter Vestergaard; E. Christiansen; Ole Hejlesen; Morten Hasselstrøm Jensen

doi:10.1089/dia.2022.2525.abstracts

Identification of Behavioural Patterns and CGM Derived Metrics for Optimising Glycaemic Control in People with T2D on Oral Semaglutide: A Trial Protocol

Nynne Sophie Holdt-Caspersen, Claus Dethlefsen, Stine Hangaard, Henrik Bengtsson, Peter Vestergaard, E. Christiansen, Ole Hejlesen, Morten Hasselstrøm Jensen

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Diabetes Technology & Therapeutics
Volume	24
Issue number	Suppl. 1
Pages (from-to)	116
ISSN	1520-9156
DOIs	https://doi.org/10.1089/dia.2022.2525.abstracts
Publication status	Published - Apr 2022
Event	15th International Conference on Advanced Technologies & Treatments for Diabetes 2022 - Online, Paris, France Duration: 8 Mar 2022 → 11 Mar 2022 Conference number: 15 https://attd.kenes.com/

Conference

Conference	15th International Conference on Advanced Technologies & Treatments for Diabetes 2022
Number	15
Location	Online
Country/Territory	France
City	Paris
Period	08/03/2022 → 11/03/2022
Internet address	https://attd.kenes.com/

Bibliographical note

EP086

Access to Document

10.1089/dia.2022.2525.abstracts

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Holdt-Caspersen, N. S., Dethlefsen, C., Hangaard, S., Bengtsson, H., Vestergaard, P., Christiansen, E., Hejlesen, O., & Jensen, M. H. (2022). Identification of Behavioural Patterns and CGM Derived Metrics for Optimising Glycaemic Control in People with T2D on Oral Semaglutide: A Trial Protocol. Diabetes Technology & Therapeutics, 24(Suppl. 1), 116. https://doi.org/10.1089/dia.2022.2525.abstracts

@article{b2271a5b9efc4a60b7f63d972b0965c3,

title = "Identification of Behavioural Patterns and CGM Derived Metrics for Optimising Glycaemic Control in People with T2D on Oral Semaglutide: A Trial Protocol",

author = "Holdt-Caspersen, {Nynne Sophie} and Claus Dethlefsen and Stine Hangaard and Henrik Bengtsson and Peter Vestergaard and E. Christiansen and Ole Hejlesen and Jensen, {Morten Hasselstr{\o}m}",

note = "EP086; 15th International Conference on Advanced Technologies & Treatments for Diabetes 2022 ; Conference date: 08-03-2022 Through 11-03-2022",

year = "2022",

month = apr,

doi = "10.1089/dia.2022.2525.abstracts",

language = "English",

volume = "24",

pages = "116",

journal = "Diabetes Technology & Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "Suppl. 1",

url = "https://attd.kenes.com/",

}

Holdt-Caspersen, NS , Dethlefsen, C , Hangaard, S, Bengtsson, H, Vestergaard, P, Christiansen, E, Hejlesen, O & Jensen, MH 2022, 'Identification of Behavioural Patterns and CGM Derived Metrics for Optimising Glycaemic Control in People with T2D on Oral Semaglutide: A Trial Protocol', Diabetes Technology & Therapeutics, vol. 24, no. Suppl. 1, pp. 116. https://doi.org/10.1089/dia.2022.2525.abstracts

Identification of Behavioural Patterns and CGM Derived Metrics for Optimising Glycaemic Control in People with T2D on Oral Semaglutide: A Trial Protocol. / Holdt-Caspersen, Nynne Sophie ; Dethlefsen, Claus ; Hangaard, Stine et al.
In: Diabetes Technology & Therapeutics, Vol. 24, No. Suppl. 1, 04.2022, p. 116.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Identification of Behavioural Patterns and CGM Derived Metrics for Optimising Glycaemic Control in People with T2D on Oral Semaglutide

T2 - 15th International Conference on Advanced Technologies & Treatments for Diabetes 2022

AU - Holdt-Caspersen, Nynne Sophie

AU - Dethlefsen, Claus

AU - Hangaard, Stine

AU - Bengtsson, Henrik

AU - Vestergaard, Peter

AU - Christiansen, E.

AU - Hejlesen, Ole

AU - Jensen, Morten Hasselstrøm

N1 - Conference code: 15

PY - 2022/4

Y1 - 2022/4

U2 - 10.1089/dia.2022.2525.abstracts

DO - 10.1089/dia.2022.2525.abstracts

M3 - Conference abstract in journal

SN - 1520-9156

VL - 24

SP - 116

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

IS - Suppl. 1

Y2 - 8 March 2022 through 11 March 2022

ER -